Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bitwise Crypto Industry Innovators ETF (BITQ) vs Stryker Corporation (SYK) Price & Performance

Bitwise Crypto Industry Innovators ETFTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

Bitwise Crypto Industry Innovators ETF vs Stryker Corporation — how do they compare? Bitwise Crypto Industry Innovators ETF trades at $23.7, while Stryker Corporation trades at $316.46 (market cap $119.25B). The key difference: Stryker Corporation pays a 1.13% dividend while Bitwise Crypto Industry Innovators ETF pays none, and Bitwise Crypto Industry Innovators ETF is trading nearer its 52-week high, Stryker Corporation nearer its low. Which is the better fit depends on your goals.

BITQSYK
Sector
Crypto-linkedTechnology
52-Week High
$30.43$403.53
52-Week Low
$16.74$282.58
Market Cap
$119.25B
Enterprise Value
$131.01B
Dividend Yield
1.13%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bitwise Crypto Industry Innovators ETF

BITQ trades at $23.18, down 3.13% today amid bearish technical signals. The stock faces selling pressure with moving averages indicating a downtrend, though oscillators show neutral conditions. Support levels cluster around $23-24 while resistance sits at $25-26. Recent news highlights investor rotation away from crypto-related ETFs as Bitcoin prices decline, creating headwinds for BITQ's performance.

The outlook remains cautious given the bearish technical setup and sector-specific challenges. Investment opportunity exists for contrarian investors betting on crypto market recovery, but risks include continued ETF outflows and regulatory uncertainty. The stock's performance remains tightly correlated with broader cryptocurrency sentiment rather than standalone fundamentals.

Stryker Corporation

Stryker (SYK) trades at $331.45, up 0.51% today, with strong analyst support (74% buy ratings) and a consensus price target of $388.44. The stock shows bullish technical signals despite a recent Q1 2026 earnings miss attributed to a temporary cyber disruption. Fundamentals remain solid with 2025 revenue of $25.12B, net income margin of 13.21%, and robust cash flow generation of $5.04B from operations.

Outlook remains positive with maintained full-year guidance and healthy end-market demand. Investment opportunity lies in the valuation discount to historical averages and innovation-driven growth. Key risks include cybersecurity vulnerabilities and competitive pressures in the medtech sector. The stock offers potential upside of 17% to consensus target with dividend stability as a Dividend Aristocrat.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bitwise Crypto Industry Innovators ETF

BITQ tracks companies at the forefront of the crypto economy, including miners, equipment suppliers, and financial service providers. It offers indirect exposure to the growth of the broader crypto ecosystem.

Read more on BITQ

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK